Overview
Dr. Matthew Hamill is interested in all aspects of Sexually Transmitted Infections (STI) and HIV. This includes, prevention, treatment, and retention in care. His research focuses on rapid, Point-of-Care diagnostics for STI in low-income settings. He provides patient-focused treatment for those with, or at risk of, STI and HIV (including Pre Exposure Prophylaxis/PrEP). He has expertise in providing care for LGBTQ+ communities. Dr. Hamill is a UK-trained physician, he received his medical degree in 1998 (MB ChB), trained in internal medicine followed by sexual health/HIV training in London, UK. He spent 3 years conducting research in Soweto, South Africa. In addition to his primary affiliation with Johns Hopkins School of Medicine, he is also affiliated with the Department of Population, Family, and Reproductive Health at the Bloomberg School of Public Health.
Dr. Hamill is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Syphilis, Gonorrhea, Urethritis, and Chlamydia.
He is actively involved in clinical research, co-authoring 92 peer reviewed articles. Dr. Hamill is currently accepting new patients.
Specialties
Licenses
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
5200 Eastern Avenue, Floor 2, Baltimore, MD 21224
Additional Areas of Focus
Dr. Hamill has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
The Johns Hopkins Hospital
Dr. Anna Durbin is an associate professor at the Johns Hopkins University School of Medicine. Her area of clinical expertise is infectious disease. Dr. Durbin earned her M.D. from Wayne State University School of Medicine. She completed her residency and performed a fellowship in infectious diseases at Detroit Medical Center. She has expertise in the evaluation of live attenuated flavivirus vaccines, primary dengue and West Nile virus vaccines, and the early evaluation of malaria vaccines. She has served on national and international advisory boards and committees related to dengue and malaria vaccine safety. An important research interest of hers is studying the immunopathogenesis of dengue infection and disease. In addition to her clinical studies, her laboratory is also developing an animal model of dengue using rhesus macaques. Dr. Durbin is highly rated in 11 conditions, according to our data. Her clinical expertise encompasses Dengue Fever, Viral Hemorrhagic Fever, Arbovirosis, and Yellow Fever. Dr. Durbin is board certified in American Board Of Internal Medicine. Dr. Durbin is currently accepting new patients.
Office
Kathleen Neuzil is an Infectious Disease provider practicing medicine in Baltimore, Maryland. Dr. Neuzil is highly rated in 9 conditions, according to our data. Her clinical expertise encompasses Typhoid Fever, Salmonella Enterocolitis, Flu, and COVID-19.
The Johns Hopkins Hospital
Mark Sulkowski, MD, is a Professor of Medicine at the Johns Hopkins University School of Medicine and the Director of the Division of Infectious Diseases at Johns Hopkins Bayview Medical Center. He also serves as the Medical Director of the Viral Hepatitis Center in the Divisions of Infectious Diseases and Gastroenterology/Hepatology in the Department of Medicine and is the Senior Associate Dean for Clinical Trials. He received his MD from Temple University School of Medicine, Philadelphia, PA (1992), pursued training in Internal Medicine at Duke University School of Medicine, Durham, NC (1995) and completed his Fellowship in Infectious Diseases (1998) at the Johns Hopkins University School of Medicine. Prof. Sulkowski has been the principal investigator for more than 120 clinical trials related to the management of viral hepatitis B and C in persons with and without HIV co-infection. He was the global principal investigator for more than a dozen trials, including the largest clinical trial of agents for the treatment of hepatitis C (New England Journal of Medicine, 2009) and the vanguard study of combination therapy with direct inhibitors of the HCV NS5A and NS5B non-structural proteins (New England Journal of Medicine, 2014). He is the past-chair of the Hepatitis Transformative Sciences Group of the National Institute of Health-funded adult AIDS Clinical Trials Group (ACTG) where he led translational studies of liver disease, namely hepatitis B and C virus. He is an elected member of the American Society for Clinical Investigation (2011) and the American Association of Physicians (2017). Prof. Sulkowski is a member of numerous professional societies including the American Association for the Study of Liver Diseases (AASLD), the European Association for the Study of the Liver (EASL), and the Infectious Diseases Society of America (IDSA). With more than 300 peer-reviewed articles, he is widely published with works in Annals of Internal Medicine, New England Journal of Medicine, JAMA, Clinical Infectious Diseases, Journal of Hepatology, and Hepatology. In 2017, 2018 and 2019, he was named as a Highly Cited Researcher (Clarivate Analytics) defined as the being in the top 1% of global researchers in 21 fields of the sciences and social sciences based on the number of citations for papers. As an invited lecturer, he has been frequently invited to present at major national and international medical congresses and has educated learners in more than 25 countries. Dr. Sulkowski is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Hepatitis C, Hepatitis, HIV/AIDS, and Hepatitis B. Dr. Sulkowski is board certified in American Board Of Internal Medicine. Dr. Sulkowski is currently accepting new patients.
Frequently Asked Questions about Dr. Matthew M. Hamill
How do I make an appointment with Dr. Matthew M. Hamill?
You can book an appointment with Dr. Matthew M. Hamill by calling their office at 410-550-2999. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Matthew M. Hamill a top-rated expert for Syphilis?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Matthew M. Hamill is classified as an Distinguished expert for Syphilis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Matthew M. Hamill specialize in?
While Dr. Matthew M. Hamill is a Infectious Disease, they have specific expertise in Syphilis, Gonorrhea, and Urethritis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Infectious Disease.
Does Dr. Matthew M. Hamill participate in research or clinical trials?
Yes. Dr. Matthew M. Hamill has published 92 articles and abstracts on conditions like Syphilis. You can view a list of Dr. Matthew M. Hamill's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Matthew M. Hamill accept my insurance?
Dr. Matthew M. Hamill accepts most major insurance plans, including Aetna and CareFirst. We recommend calling the office directly at 410-550-2999 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- GonorrheaDr. Hamill isDistinguished. Learn about Gonorrhea.
- SyphilisDr. Hamill isDistinguished. Learn about Syphilis.
- UrethritisDr. Hamill isDistinguished. Learn about Urethritis.
- Advanced
- ChlamydiaDr. Hamill isAdvanced. Learn about Chlamydia.
- HIV/AIDSDr. Hamill isAdvanced. Learn about HIV/AIDS.
- Lymphogranuloma VenereumDr. Hamill isAdvanced. Learn about Lymphogranuloma Venereum.
- MonkeypoxDr. Hamill isAdvanced. Learn about Monkeypox.
- NeurosyphilisDr. Hamill isAdvanced. Learn about Neurosyphilis.
- TrichomoniasisDr. Hamill isAdvanced. Learn about Trichomoniasis.
- Experienced
- AIDS Dementia ComplexDr. Hamill isExperienced. Learn about AIDS Dementia Complex.
- AIDS Dysmorphic SyndromeDr. Hamill isExperienced. Learn about AIDS Dysmorphic Syndrome.
- COVID-19Dr. Hamill isExperienced. Learn about COVID-19.
- Genital HerpesDr. Hamill isExperienced. Learn about Genital Herpes.
- MenopauseDr. Hamill isExperienced. Learn about Menopause.
- MyelitisDr. Hamill isExperienced. Learn about Myelitis.
- Severe Acute Respiratory Syndrome (SARS)
- SmallpoxDr. Hamill isExperienced. Learn about Smallpox.